Milyrataj-IV 1mg Injection
Prescription Required
Product introduction
Milyrataj-IV 1mg Injection is a medicine used for short-term treatment of heart failure. It is also used to treat patients with a poorly functioning heart after heart surgery. It makes the heart pump blood more efficiently.
Milyrataj-IV 1mg Injection is a medicine used for short-term treatment of heart failure. It is also used to treat patients with a poorly functioning heart after a heart surgery. It makes the heart pump blood more efficiently. It is useful when patients are not adequately relieved by other medicines. This medicine is given as a drip, under the supervision of a doctor. Continuous monitoring of heart rate and blood pressure is required while using this medicine. Side effects like hypotension (low blood pressure), arrhythmia (abnormal heart rhythm), and headache may be seen in some patients.
Milyrataj-IV 1mg Injection is a medicine used for short-term treatment of heart failure. It is also used to treat patients with a poorly functioning heart after a heart surgery. It makes the heart pump blood more efficiently. It is useful when patients are not adequately relieved by other medicines. This medicine is given as a drip, under the supervision of a doctor. Continuous monitoring of heart rate and blood pressure is required while using this medicine. Side effects like hypotension (low blood pressure), arrhythmia (abnormal heart rhythm), and headache may be seen in some patients.
Uses of Milyrataj-IV Injection
Benefits of Milyrataj-IV Injection
In Heart failure
Heart failure means your heart is weak and cannot pump enough blood to your lungs and the rest of your body. The most common symptoms are breathlessness, tiredness, and swelling in your legs, ankles, abdomen and other parts of your body. Milyrataj-IV 1mg Injection makes it easier for your heart to pump blood around your body and is therefore an effective treatment for heart failure.
This medicine will help relieve your symptoms, making you feel better and more energetic. You should make appropriate lifestyle changes (such as eating healthily and keeping active) to help this medicine be effective. Follow your doctor’s instructions carefully to get maximum benefit.
This medicine will help relieve your symptoms, making you feel better and more energetic. You should make appropriate lifestyle changes (such as eating healthily and keeping active) to help this medicine be effective. Follow your doctor’s instructions carefully to get maximum benefit.
Side effects of Milyrataj-IV Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Milyrataj-IV
- Hypotension (low blood pressure)
- Headache
- Arrhythmia (irregular heartbeats)
- Tachycardia
How to use Milyrataj-IV Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Milyrataj-IV 1mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Milyrataj-IV 1mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Milyrataj-IV 1mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Milyrataj-IV 1mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CAUTION
Milyrataj-IV 1mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Milyrataj-IV 1mg Injection may be needed. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Milyrataj-IV 1mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Milyrataj-IV 1mg Injection may not be needed in these patients. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- If mild burning or pain at the injection site bothers you consult with your doctor.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
Fact Box
Chemical Class
Bipyridines and Oligopyridines Derivative
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Phosphodiesterase-III inhibitors (HF)
Patient concerns
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Maron BA, Rocco TP. Pharmacotherapy of Congestive Heart Failure. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 805.
- Teerlink JR, Sliwa K, Opie LH. Heart Failure. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 181-83.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 921-22.
- Milrinone. Guildford, Surrey: SANOFI; 1989 [revised 19 Jun. 2018]. [Accessed 19 Mar. 2019] (online) Available from:
- Drugs.com. Milrinone Pregnancy and Breastfeeding Warnings. [Accessed 19 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from:
Marketer details
Name: Taj Pharma India Ltd
Address: first floor, 15-6-108 afzal gunj, hyderabad, telangana 500012
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹1177
Inclusive of all taxes
10.0 ml in 1 vial
SOLD OUT
Notify me